Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: The nucleoside inflammation, coagulation and endothelial function (NICE) study

David A. Wohl*, Gretchen Arnoczy, Carl J. Fichtenbaum, Thomas Campbell, Babafemi Taiwo, Charles Hicks, Grace A. McComsey, Susan Koletar, Paul Sax, Pablo Tebas, Belinda Ha, Kelly Massengale, Kendall Walsh, James H. Stein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint Dive into the research topics of 'Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: The nucleoside inflammation, coagulation and endothelial function (NICE) study'. Together they form a unique fingerprint.

Medicine & Life Sciences